135 related articles for article (PubMed ID: 36929300)
1. Association of proprotein convertase subtilisin/kexin type 9 (PCSK9) levels with abnormally high ankle-brachial index in atrial fibrillation.
Menichelli D; Galardo G; Cammisotto V; Bartimoccia S; Carnevale R; Pignatelli P; Pastori D
Kardiol Pol; 2023; 81(4):381-387. PubMed ID: 36929300
[TBL] [Abstract][Full Text] [Related]
2. Interaction between serum endotoxemia and proprotein convertase subtilisin/kexin 9 (PCSK9) in patients with atrial fibrillation: A post-hoc analysis from the ATHERO-AF cohort.
Pastori D; Ettorre E; Carnevale R; Nocella C; Bartimoccia S; Del Sordo E; Cammisotto V; Violi F; Pignatelli P;
Atherosclerosis; 2019 Oct; 289():195-200. PubMed ID: 31303312
[TBL] [Abstract][Full Text] [Related]
3. Relationship of PCSK9 and Urinary Thromboxane Excretion to Cardiovascular Events in Patients With Atrial Fibrillation.
Pastori D; Nocella C; Farcomeni A; Bartimoccia S; Santulli M; Vasaturo F; Carnevale R; Menichelli D; Violi F; Pignatelli P;
J Am Coll Cardiol; 2017 Sep; 70(12):1455-1462. PubMed ID: 28911508
[TBL] [Abstract][Full Text] [Related]
4. Proprotein convertase subtilisin/kexin type 9 (PCSK9), soluble lectin-like oxidized LDL receptor 1 (sLOX-1) and ankle brachial index in patients with differentiated thyroid cancer.
Ozkan C; Akturk M; Altinova AE; Cerit ET; Gulbahar O; Yalcin MM; Cakir N; Balos Toruner F
Endocr J; 2015; 62(12):1091-9. PubMed ID: 26490048
[TBL] [Abstract][Full Text] [Related]
5. Plasma proprotein convertase subtilisin/kexin type 9 concentration and recurrent cardiovascular events in patients with familial hypercholesterolemia.
Cao YX; Liu HH; Jin JL; Sun D; Guo YL; Wu NQ; Zhu CG; Xu RX; Sun J; Santos RD; Li JJ
Eur J Prev Cardiol; 2021 Apr; 28(3):272-279. PubMed ID: 33891693
[TBL] [Abstract][Full Text] [Related]
6. Association of Peripheral Artery Disease With Incident Atrial Fibrillation: The ARIC (Atherosclerosis Risk in Communities) Study.
Bekwelem W; Norby FL; Agarwal SK; Matsushita K; Coresh J; Alonso A; Chen LY
J Am Heart Assoc; 2018 Apr; 7(8):. PubMed ID: 29666066
[TBL] [Abstract][Full Text] [Related]
7. Association between proprotein convertase subtilisin/kexin type 9 and subclinical cerebrovascular disease in the community.
Kunimura A; Yano Y; Hisamatsu T; Torii S; Kondo K; Kadota A; Fujiyoshi A; Okamura T; Watanabe Y; Shiino A; Nozaki K; Ueshima H; Miura K;
Eur J Neurol; 2023 May; 30(5):1327-1334. PubMed ID: 36727585
[TBL] [Abstract][Full Text] [Related]
8. Relationship between Serum Proprotein Convertase Subtilisin/Kexin Type 9 Concentration and Prevalence of Coronary Artery Calcium in a Community-Based Sample of Japanese Men.
Kunimura A; Miura K; Segawa H; Torii S; Kondo K; Hisamatsu T; Kadota A; Fujiyoshi A; Yano Y; Nakagawa Y; Okamura T; Ueshima H
J Atheroscler Thromb; 2023 Jul; 30(7):767-777. PubMed ID: 36123046
[TBL] [Abstract][Full Text] [Related]
9. Association of serum proprotein convertase subtilisin/kexin type 9 with early atherosclerosis in newly diagnosed type 2 diabetes mellitus.
Guo W; Gong Y; Li J; Qin P; Lu J; Li X; Zhu W; Xu N; Zhou H; Zhang Q
Nutr Metab Cardiovasc Dis; 2019 Aug; 29(8):815-821. PubMed ID: 31133497
[TBL] [Abstract][Full Text] [Related]
10. Ankle-Brachial Index and cardiovascular events in atrial fibrillation. The ARAPACIS Study.
Violi F; Davì G; Proietti M; Pastori D; Hiatt WR; Corazza GR; Perticone F; Pignatelli P; Farcomeni A; Vestri AR; Lip GY; Basili S;
Thromb Haemost; 2016 Apr; 115(4):856-63. PubMed ID: 26740316
[TBL] [Abstract][Full Text] [Related]
11. Ankle--brachial index, vascular calcifications and mortality in dialysis patients.
Adragao T; Pires A; Branco P; Castro R; Oliveira A; Nogueira C; Bordalo J; Curto JD; Prata MM
Nephrol Dial Transplant; 2012 Jan; 27(1):318-25. PubMed ID: 21551082
[TBL] [Abstract][Full Text] [Related]
12. Relationship between low Ankle-Brachial Index and rapid renal function decline in patients with atrial fibrillation: a prospective multicentre cohort study.
Violi F; Pastori D; Perticone F; Hiatt WR; Sciacqua A; Basili S; Proietti M; Corazza GR; Lip GY; Pignatelli P;
BMJ Open; 2015 May; 5(5):e008026. PubMed ID: 25998039
[TBL] [Abstract][Full Text] [Related]
13. Heart rate significantly influences the relationship between atrial fibrillation and ankle-brachial index.
Hsu PC; Lee WH; Chu CY; Lin TH; Su HM; Lee CS; Voon WC; Lai WT; Sheu SH
J Cardiol; 2015 Aug; 66(2):143-7. PubMed ID: 25500429
[TBL] [Abstract][Full Text] [Related]
14. Circulating proprotein convertase subtilisin-kexin type 9, all-cause mortality, and cardiovascular mortality: The Ludwigshafen Risk and Cardiovascular Health study.
Silbernagel G; Scharnagl H; Kleber ME; Stojakovic T; März W
Eur J Prev Cardiol; 2017 Jul; 24(10):1095-1101. PubMed ID: 28436724
[TBL] [Abstract][Full Text] [Related]
15. Relation of Proprotein Convertase Subtilisin/Kexin Type 9 to Cardiovascular Outcomes in Patients Undergoing Percutaneous Coronary Intervention.
Choi IJ; Lim S; Lee D; Lee WJ; Lee KY; Kim MJ; Jeon DS
Am J Cardiol; 2020 Oct; 133():54-60. PubMed ID: 32798044
[TBL] [Abstract][Full Text] [Related]
16. Proprotein convertase subtilisin/kexin type 9 is associated with atherosclerosis in patients with Behcet's disease.
Aydogan Baykara R; Yilmaz PD; Göktepe MH; Kadiyoran C; Ogul M; Kucuk A; Cumhur Cüre M; Cüre E
Clin Exp Hypertens; 2022 Jul; 44(5):480-486. PubMed ID: 35502687
[TBL] [Abstract][Full Text] [Related]
17. Association of circulating PCSK9 concentration with cardiovascular metabolic markers and outcomes in stable coronary artery disease patients with or without diabetes: a prospective, observational cohort study.
Peng J; Liu MM; Jin JL; Cao YX; Guo YL; Wu NQ; Zhu CG; Dong Q; Sun J; Xu RX; Li JJ
Cardiovasc Diabetol; 2020 Oct; 19(1):167. PubMed ID: 33023603
[TBL] [Abstract][Full Text] [Related]
18. Low Ankle-Brachial Index Is Associated With Stroke Recurrence in Ischemic Stroke Patients With Atrial Fibrillation.
Han M; Baik M; Kim YD; Choi J; Seo K; Park E; Heo JH; Nam HS
Front Neurol; 2021; 12():705904. PubMed ID: 34744961
[No Abstract] [Full Text] [Related]
19. Association of circulating proprotein convertase subtilisin/kexin type 9 levels and the risk of incident type 2 diabetes in subjects with prediabetes: a population-based cohort study.
Shi J; Zhang W; Niu Y; Lin N; Li X; Zhang H; Hu R; Ning G; Fan J; Qin L; Su Q; Yang Z
Cardiovasc Diabetol; 2020 Dec; 19(1):209. PubMed ID: 33302966
[TBL] [Abstract][Full Text] [Related]
20. Plasma Levels of Proprotein Convertase Subtilisin/Kexin Type 9 Are Elevated in Patients With Peripheral Artery Disease and Associated With Metabolic Disorders and Dysfunction in Circulating Progenitor Cells.
Chao TH; Chen IC; Li YH; Lee PT; Tseng SY
J Am Heart Assoc; 2016 May; 5(5):. PubMed ID: 27207972
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
